Mr. Guy Bourgeois reports

G6 MATERIALS PROVIDES UPDATE ON STATUS OF MCTO

G6 Materials Corp. is providing this update on the status of a management cease trade order granted on Oct. 2, 2024 (the MCTO), by the British Columbia Securities Commission under National Policy 12-203 -- Management Cease Trade Order (NP 12-203). On Oct. 2 and further clarified on Oct. 7, 2024, the company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management's discussion and analysis for the fiscal year ended May 31, 2024 (the annual filings), beyond the period prescribed under applicable Canadian securities laws.

The company reports that it is in the progress of completing the annual filings and will provide a further update on the timing on or about Oct. 30, 2024. Additionally, the company is currently working on its interim financial statements and management's discussion and analysis for the first quarter ended Aug. 31, 2024, with a timing update expected around Oct. 30, 2024. Further updates will be provided by the company as necessary.

During the MCTO, the general investing public will continue to be able to trade in the company's listed common shares. However, the company's chief executive office and chief financial officer will not be able to trade in the company's common shares.

Other than as disclosed in this news release, there are no material changes to the information contained in the default announcement. The company confirms that it intends to satisfy the provisions of NP 12-203 and will continue to issue biweekly default status reports for so long as it remains in default of the annual filings requirement.

About G6 Materials Corp.

G6 Materials is a high-tech company with expertise in advanced materials that creates value developing innovative composites for a wide range of industrial uses. Graphene Laboratories Inc., a wholly owned subsidiary of G6, sells a range of graphene-based products and other materials, including but not limited to conductive epoxies, high-performance composites, and R&D (research and development) materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. Graphene Laboratories Inc. has entered the global air filtration market with Breathe+, a line of medical-grade HEPA air filtration products enhanced with advanced performance graphene material.

G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the company has a valuable IP (intellectual property) portfolio currently comprising seven granted patents. The company's management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Graphene Laboratories has established its premium research laboratory and scalable production facility equipped with advanced analytical and material processing equipment.

We seek Safe Harbor.